Tuberc Respir Dis > Volume 59(1); 2005 > Article
Tuberculosis and Respiratory Diseases 2005;59(1):62-68.
DOI: https://doi.org/10.4046/trd.2005.59.1.62    Published online July 1, 2005.
Clinical Experience of Silicone Airway Stent in the Management of Benign Tracheobronchial Stenosis.
Yon Ju Ryu, Chang Min Yu, Jae Chul Choi, Yong Soo Kwon, Hojoong Kim, Jhingook Kim, Soo Won Suh
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Seoul, Korea. hjkim@smc.samsung.co.kr
Abstract
BACKGROUND
The clinical results of a Natural stent in patients with a benign tracheobronchial stenosis were examined by comparing the clinical outcomes and complications of those patients who underwent Dumon and Natural stenting in the management of benign airway stenosis. METHODS: The medical records of 94 patients (39 Dumon and 55 Natural stent) with a benign tracheobronchial stenosis were reviewed and analyzed. RESULTS: Post-tuberculous stenosis was the leading indication for airway stenting (74%), which was followed by post-intubation stenosis (21%). After intervention, the dyspnea had improved among those patients who underwent Dumon (90%) and Natural (86%) stenting. After stabilizing the dyspnea, the stent could be successfully removed in half of the patients who underwent both Dumon (54%) and Natural (49%) stenting. During the 42 month follow-up period, the complication rate was similar in those patients who underwent Dumon and Natural stenting: migration (46% vs 53%), granulation tissue formation (36% vs 49%), mucostasis (21% vs 16%) and restenosis (51% vs 36%). CONCLUSION: The clinical results of Natural airway stent was similar to those of Dumon stent in the management of benign tracheobronchial stenosis.
Key Words: Bronchoscopy, Tuberculosis, Airway obstruction, Tracheal stenosis


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next